Germany’s Merck KGaA Takes a Giant Leap: $3.9 Billion Acquisition of US Biotech Firm SpringWorks!
Germany's Merck KGaA has unveiled an exciting $3.9 billion agreement to acquire the innovative US biotech firm SpringWorks. This strategic ...
Read more
